Skip to main content
. 2018 Sep 11;9(71):33549–33561. doi: 10.18632/oncotarget.26088

Figure 2. Rapamycin and Triciribine reduce the migratory potentials of human neuronal and glial cancer cell lines.

Figure 2

A scratch was made in a six-well plate of confluent U251 and SH-SY5S cells using a 200 μl tip, and images were taken at T = 0, 24, and 48 h with or without treatment, and quantification of the distance of the wound closure was assessed over time (A, B). Results are expressed as a percentage of each group compared to its condition at T = 0 h. Data represent an average of three independent experiments. The data are reported as mean ± SEM (p < 0.001; Two-way ANOVA; ***P < 0.001; different treatments compared to control at this time point, Bonferroni’s multiple comparison test).